|

Sugemalimab and Chemotherapy Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1

Top Sponsors

  • Peking Union Medical College1
  • Hunan Cancer Hospital1

Indications

  • Lung Cancer2
  • Cancer2
  • Carcinoma, Non-Small-Cell Lung1
  • NSCLC1

Other2 trials

A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
Phase 2
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.